Zhu Pirot, PhD

Vice President, Translational Sciences

Zhu Pirot is the Vice President of Translational Sciences at Kriya Therapeutics. Dr. Pirot joins Kriya from Sangamo Therapeutics, where she was the head of analytical method development, CMC lead where she built and led the analytical function for AAV-mediated gene therapy, gene editing, and cell therapy programs. Dr. Pirot has more than 20 years of experience in drug development and has held positions of increasing responsibility at Chiron, Avigen, and Geron.

Dr. Pirot received her MD from Inner Mongolia Medical College, her PhD in cellular and molecular biology from the University of Turin and her master’s degree in cytogenetics from the Beijing Cancer Institute.